Managers

Beam Therapeutics attracts $87 mln Series A

Cambridge, Massachusetts-based Beam Therapeutics, a developer of precision genetic medicines through base editing, has raised up to $87 million in Series A funding. F-Prime Capital Partners and ARCH Venture Partners led the round.

VC-backed Complexa recruits Salva as CEO and president

Berwyn, Pennsylvania-based Complexa Inc, a biopharmaceutical company, has named Francisco D. Salva as CEO and president. His appointment is effective immediately. Previously, Salva was founder and vice president of operations for Acerta Pharma B.V. Complexa's backers include Andera Partners, HBM Healthcare Investments, JAFCO, New Enterprise Associates and Pfizer Venture Investments.

Qventus raises $30 mln

Mountain View, California-based Qventus, a provider of AI-based software platform for hospital operations management, announced that it has secured $30 million in Series B funding from Bessemer Venture Partners. New York-Presbyterian Hospital also participated in the round with existing investors Mayfield and Norwest Venture Partners. As part of the funding round, Stephen Kraus, partner at Bessemer, has joined the board. The company, founded in 2012, has now raised more than $43 million in total funding.

The hidden costs of web migration – four areas for digital due diligence

April Dashboard: M&A picks up as fundraising levels out

CRV raises $600 mln for early-stage and growth investing

Bi-coastal venture firm CRV announced it has raised $600 million for its 17th fund. The firm raised near $400 million for its previous fund, which closed in 2014. The new vehicle will invest in early-stage tech, but with an additional mandate for growth investing. Fund XVII will focus on the enterprise, consumer and bioengineering sectors. Source: Medium blog post

Keiretsu Capital secures $4.2 million first close of a blockchain fund of funds

Keiretsu Capital said it completed a $4.2 million first close of a blockchain fund of funds and anticipates a second close in June, with commitments so far of $1.5 million.

U.S. investors receive more in compensation than their peers in Europe, Canada: survey

Most LPs don’t ask about sexual harassment when assessing a manager: survey

Entrée Capital wraps up sophomore Israel-focused early-stage fund at $80 mln

Entrée Capital has closed its second Israeli-focused early-stage fund at $80 million. Also, the venture firm has hired Ran Achituv as a managing partner and promoted Eran Bielski to general partner. Entrée Capital has offices in London, San Francisco and Herzliya, Israel.